🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Dexmedetomidine and Agitation After Nasal Surgery

RecruitingNAAges 18 Years - 50 YearsAllFayoum University Hospital
NCT06867302 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The main objective of study is to compare dexmedetomidine single bolus dose before extubation with continuous infusion as regards their efficacy in mitigating the incidence of emergence agitation in obese adults undergoing nasal surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * American Society of Anesthesiologist (ASA) Ⅰ or II * Adults with body mass index (BMI) \< 30 Kg/m * Underwent elective nasal surgery. Exclusion Criteria: * Significant comorbidity like hepatic, renal, or cardiac disease * Auditory impairment * Cognitive dysfunction * Substance abuse * Allergy to the studied medicines * Planned intensive care admission after the surgery.
💊

What it tests

  • Dexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML)
  • Dexmedetomidine Injection [Precedex]
📍

Where

1 site
Fayoum University Hospital
Al Fayyum, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy